Literature DB >> 11994510

Antagonistic effects of IL-4 and TGF-beta1 on Langerhans cell-related antigen expression by human monocytes.

G Guironnet1, C Dezutter-Dambuyant, C Vincent, N Bechetoille, D Schmitt, J Péguet-Navarro.   

Abstract

In this study, we analyzed the specific effects of transforming growth factor beta (TGF-beta1) and/or IL-4 on monocyte-derived cells. Monocytes were cultured with GM-CSF, GM-CSF/TGF-beta1, GM-CSF/IL-4, or GM-CSF/IL-4/TGF-beta1 before cell morphology, phenotype, and function were assessed. As expected, interleukin-4 is mandatory for monocyte differentiation into potent allostimulatory DC. In its absence, monocyte-derived cells share many phenotypic and functional features with macrophages. However, it is interesting that the cells express E-cadherin, independent of exogenous TGF-beta1, and addition of the cytokine induced CCR6 expression. Most importantly, a subset of monocytes cultured with GM-CSF/TGF-beta1 expresses Langerin, as confirmed by electron microscopy analysis. Langerin engagement with specific monoclonal antibodies induces its internalization and the formation of typical Birbeck granules. Monocytes cultured in GM-CSF/IL-4 did not express the LC markers E-cadherin, CCR6, or Langerin. The simultaneous addition of TGF-beta1 allows most of the cells to express E-cadherin but rarely CCR6 and Langerin. Taken together, the results add further evidence that LC can derive from monocytes and demonstrate an antagonistic effect of IL-4 and TGF-beta1 on monocyte differentiation toward the LC pathway.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11994510

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  8 in total

1.  Differentiation of Langerhans Cells from Monocytes and Their Specific Function in Inducing IL-22-Specific Th Cells.

Authors:  Yohei Otsuka; Eri Watanabe; Eiji Shinya; Sadayuki Okura; Hidehisa Saeki; Teunis B H Geijtenbeek; Hidemi Takahashi
Journal:  J Immunol       Date:  2018-10-15       Impact factor: 5.422

2.  Decreased migration of Langerhans precursor-like cells in response to human keratinocytes expressing human papillomavirus type 16 E6/E7 is related to reduced macrophage inflammatory protein-3alpha production.

Authors:  Jennifer C Guess; Dennis J McCance
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

3.  UV Radiation Induces the Epidermal Recruitment of Dendritic Cells that Compensate for the Depletion of Langerhans Cells in Human Skin.

Authors:  Amine Achachi; Marc Vocanson; Philippe Bastien; Josette Péguet-Navarro; Sophie Grande; Catherine Goujon; Lionel Breton; Isabelle Castiel-Higounenc; Jean-François Nicolas; Audrey Gueniche
Journal:  J Invest Dermatol       Date:  2015-03-25       Impact factor: 8.551

Review 4.  Theiler's virus infection: a model for multiple sclerosis.

Authors:  Emilia L Oleszak; J Robert Chang; Herman Friedman; Christos D Katsetos; Chris D Platsoucas
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

5.  Modulation of beta-catenin and E-cadherin interaction by Vpu increases human immunodeficiency virus type 1 particle release.

Authors:  Aneeza Salim; Lee Ratner
Journal:  J Virol       Date:  2008-02-06       Impact factor: 5.103

6.  Simian virus 40 inhibits differentiation and maturation of rhesus macaque DC-SIGN(+) dendritic cells.

Authors:  C Changyong; M Sun; H Li; N Brockmeyer; Nan Ping Wu
Journal:  Eur J Med Res       Date:  2010-09-24       Impact factor: 2.175

Review 7.  Ligand recognition by antigen-presenting cell C-type lectin receptors.

Authors:  Eamon P McGreal; Joanna L Miller; Siamon Gordon
Journal:  Curr Opin Immunol       Date:  2005-02       Impact factor: 7.486

8.  Human beta-defensin 3 induces maturation of human langerhans cell-like dendritic cells: an antimicrobial peptide that functions as an endogenous adjuvant.

Authors:  Laura K Ferris; Yvonne K Mburu; Alicia R Mathers; Eric R Fluharty; Adriana T Larregina; Robert L Ferris; Louis D Falo
Journal:  J Invest Dermatol       Date:  2012-09-06       Impact factor: 8.551

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.